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Abstract
The inositol (1,4,5) trisphosphate 3-kinases comprise a family of enzymes (A, B, and C) that phosphorylate the calcium
mobilising molecule inositol (1,4,5) trisphosphate (IP3) to generate inositol (1,3,4,5) tetrakisphosphate. This molecule can
function as a second messenger, but its roles are not completely understood. The A isoform of inositol (1,4,5) trisphosphate
3-kinase localises to filamentous actin within dendritic spines in the hippocampus and is implicated in the regulation of
spine morphology and long term potentiation, however the mechanisms through which it signals in neuronal cells are not
completely understood. We have used NGF driven neurite outgrowth from PC12 cells as a platform to examine the impact
of signaling via inositol (1,4,5) trisphosphate 3-kinase activity in a neuronal cell. We have found that the catalytic activity of
the enzyme opposes neurite outgrowth, whilst pharmacological inhibition of inositol (1,4,5) trisphosphate 3-kinase leads to
a significant increase in neurite outgrowth, and we show that the reduction in neurite outgrowth in response to inositol
(1,4,5) trisphosphate 3-kinase activity correlates with reduced ERK activity as determined by western blotting using
phosphorylation-specific antibodies. Our findings suggest a novel neuronal signaling pathway linking metabolism of IP3 to
signaling via ERK.
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Introduction
Numerous ligand-operated signaling pathways involve the
second-messenger inositol (1,4,5) trisphosphate (IP3), which is
generated by the action of phospholipase C (PLC) on phop-
sphatidylinositol (4,5) bisphosphate (PIP2). Once generated, IP3
can either be metabolized by IP3 5-phosphatases to generate the
inactive inositol bisphosphate (IP2), or can be further phosphor-
ylated by a family of IP3 3-kinases, to generate inositol (1,3,4,5)
tetrakisphosphate (IP4). IP3 is a second messenger which functions
by binding to the IP3 receptor at the ER, resulting in the release of
stored calcium [1]. IP4 is also recognized as a second messenger
but its cellular functions are not fully understood [2,3,4]. There are
three isoforms of IP3 3-kinase. These have been designated A, B
and C (IP3 3-KA, IP3 3-KB and IP3 3-KC) [5]. IP3 3-KB and IP3
3-KC are expressed in most tissues, whilst IP3 3-KA expression is
enriched in the central nervous system [6,7,8]. IP3 3-KB is the
most studied of the three isoforms; it has been assigned roles in the
regulation and development of various cells in the immune system,
functioning principally via the production of IP4. Three studies
have implicated IP3 3-KB in the development of T-cells [9,10,11],
and it has also been implicated in B-cell development, selection
and activation [12,13,14], as well as the regulation of myelopoesis
and neutrophil signaling [15,16]. However, whilst these studies
have been instrumental in defining a physiological role for IP3 3-
KB, the cellular roles of IP4 remain unclear and the mechanisms
by which it signals require elucidation. Some studies suggest that
IP4 production in T-cells is necessary for efficient activation of the
ERK pathway [9,10], whilst it is also necessary for the activation
of PLC in order for T-cells to develop correctly [11]. Others
suggest that, in B-cells, IP4 signals solely by inhibiting store
operated calcium channels [13,14], whilst it is also reported that
IP4 negatively regulates PIP2 mediated activation of the GTPase
activating protein Gap1IP4BP resulting in attenuated signaling via
ERK [12]. To further complicate the issue, it has been reported
that IP4 negatively regulates phosphatidylinositol (3,4,5)-trispho-
sphate (PIP3) signaling in neutrophils [15,16]. It is therefore
evident that IP4 (as generated by IP3 3-kinase) has the ability to
impact on numerous key signaling pathways depending on factors
such as the cell type in which IP4 is produced. In the brain, IP3 3-
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KA is enriched in dendritic spines in the CA1 region of the
hippocampus [8], and is upregulated during spatial learning tasks
[17]. It is also implicated in the regulation of long term
potentiation (LTP) via the generation of IP4 [18,19], and regulates
dendritic spine morphology by functioning as a scaffold for Rac1
[20], and as an F-actin-bundling protein [21]. However the full
consequences of its catalytic activity in neurons are not clear.
We chose to investigate the consequences of IP3 3-KA expression
in a neuroendocrine cell line during differentiation to a neuronal
phenotype. PC12 cells respond to NGF stimulation by halting
proliferation, extending neurites and adopting a neuronal phenotype.
This differentiation process occurs as a result of the binding of NGF to
the TrkA receptor, which activates a number of well characterized
signaling pathways [22]. We therefore chose to use NGF driven
neurite outgrowth as a platform to investigate the potential
consequences of IP3 3-KA activity in neuronal cells. We report that
stable high expression of IP3 3-KA dramatically inhibits neurite
outgrowth from PC12 cells after NGF stimulation. We present
evidence that this inhibition is most likely as a result of IP4 production,
and occurs due to the subsequent attenuation of signaling via ERK.
Materials and Methods
Expression constructs
pEGFP-C3-IP3 3-KA, containing the full length rat inositol
1,4,5-trisphosphate 3-kinase A coding sequence cloned into the
HindIII and BamH1 restriction sites of pEGFP-C3 (Clontech) [8].
66-459 pEGFP-C3-IP3 3-KA, containing bp198–1353 of the rat
inositol 1,4,5-trisphosphate 3-kinase A coding sequence ligated
into the HindIII and BamH1 restriction sites of pEGFP-C3 [8].
D260A/K262A pEGFP-C3-IP3 3-KA, containing the rat inositol
1,4,5-trisphosphate 3-kinase A coding sequence ligated into the
HindIII and BamH1 restriction sites (as above), but with D260A
and K262A point mutations [23]. All of these constructs were a
gift from Dr. Michael Schell, Uniformed Services University of the
Health Sciences, USA.
PC12 cell culture
Low passage number PC12 cells were acquired from the
European Collection of Cell Cultures (ECACC), and routinely
grown in RPMI 1640 media (Sigma) supplemented with 10% batch
tested French FBS (Biosera), 1% penicillin/streptomycin, and
2 mM L-glutamine on flasks coated with type IV collagen (Sigma),
according to ECACC guidelines. PC12 cells were differentiated in
the usual media supplemented with 100 ng/ml NGF (Sigma).
Generation of stable PC12 cell lines expressing GFP
tagged constructs
PC12 cells were transfected with plasmid DNA using lipofectamine
2000 (Invitrogen) on 90 mm petri dishes and grown in the usual
media plus 400 mg/ml neomycin (G418, Invitrogen). In order to
generate clonal lines, cultures were left in selective media until isolated
colonies were visible. These were screened for GFP expression, and
isolated using sterile cloning rings and expanded in selective culture
media. Observations of stable cell lines were made using several
clonal lines to ensure against artefacts of clonal expression. Individual
clonal lines were then selected for FACS sorting.
FACS sorting
Flow cytometric analysis and sorting were performed using a
MoFlo Fluorescence Activated Cell Sorter (Cytomation), or the BD
FACS Vantage SE system (BD Biosciences). Cells derived from a
single clonal line were sorted at 488 nm by virtue of their GFP signal
to enrich for the approximate 25% of the cell population expressing
the highest levels of fluorescence, and the approximate 25% of the
population expressing the lowest levels of fluorescence.
Confocal Microscopy
Cell imaging was performed by confocal microscopy using a
Leica TCS-NT confocal laser-scanning microscope attached to a
Leica DM RBE upright epifluorescence microscope under a 636
oil immersion objective. Fluorophores were excited at 488 nm and
568 nm using a krypton/argon laser. Images shown are maximum
projections of stacks of confocal slices obtained throughout the
entire depth of neurites. Images were processed using Adobe
Photoshop 6.0 and Adobe Illustrator 10 (2).
Quantitative Analysis of Neurite Outgrowth
Indices of neurite outgrowth were quantified using the
Cellomics Arrayscan high content imaging system, using a 106
objective to acquire images of fluorescently labelled cells via
automated microscopy. Images were then analysed using a
dedicated proprietary algorithm (Cellomics). For experiments to
determine the effects of stable expression on neurite outgrowth,
cells were plated onto 96 well plates at a density of 2500 cells per
well into 100 ml of the usual supplemented media containing
100 ng/ml NGF. Cells were cultured in the presence of NGF and
fixed for analysis after four days. For the experiments to determine
the effect of C5 inhibition of IP3 3-kinase and XeC inhibition of
the IP3 receptor, cells were plated in the presence of NGF and
drug or vehicle (DMSO) on day one, and fixed on day four. All
experiments were performed a minimum of three times. Cells were
fixed with 4% paraformaldehyde containing 10% sucrose and
0.06% Hoescht 33342 dye (to label nuclei). Cells were then
washed with a proprietary buffer (Cellomics), and labelled (by
indirect immunofluorescence) with a proprietary antibody (Cello-
mics) to detect neurites, (Cellomics NOG HitKit). The Arrayscan
was then used to capture images of Hoescht 33342-labelled nuclei,
in order to identify individual cells, and then images were acquired
of the fluorescently labelled neurites. Cellomics image analysis
software (Neurite Outgrowth Algorithm) was then used to quantify
neurite outgrowth. For this study these included the neurite
outgrowth index and the average neurite length. The neurite
outgrowth index is a measure of neurite bearing cells, and is
defined as the percentage of neurons whose summed lengths are
greater than a set threshold. This was set at 10 mm longer than the
average width of a cell body, which was set at 15 mm. The origin
of neurites was determined by the Hoescht label.
The average neurite length was calculated as the sum of neurite
lengths from cells with outgrowth divided by the number of cells
with outgrowth. Neurites and cell bodies were identified using the
Cellomics Neurite Outgrowth HitKit, which uses a proprietary
neuronal marker as a primary antibody, visualised with a
secondary antibody conjugated to Alexa 488.
Analysis of ERK activity
For experiments to determine ERK activity, serum starved PC12
cells were stimulated with 1 ng/ml NGF and lysed after various
time points. ERK activity was then determined by western blot. A
rabbit polyclonal antibody recognising p44/42 MAP Kinase (Cell
Signalling Technology) was used to detect total ERK, whilst a rabbit
polyclonal antibody recognising phospho-p44/42 MAP Kinase
(Thr202/Tyr204) was used to detect Phosphorylated ERK. The
phospho-specific antibody detects rat p42 and p44 MAP kinase
(ERK2 and ERK1) only when phosphorylated at Thr202 and
Tyr204 (Cell Signalling Technology). Primary antibody was
detected using a horseradish peroxidase conjugated secondary
antibody (DAKO) and visualised by enhanced chemiluminescence.
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Pharmacological agents
The following small molecule inhibitors were used: Inositol
1,4,5-trisphosphate 3-Kinase inhibitor referred to as ‘‘C5’’, N2-(m-
Trifluorobenzyl), N6-(p-nitrobenzyl) purine (Calbiochem/Merck)
[24]. Xestospongin C, an inhibitor of IP3-mediated calcium
release (Calbiochem/Merck) [25].
Statistical Analysis
Data presented represent means of three experiments +/2
SEM. Statistical analysis was performed using one-way ANOVA
with post-hoc analysis, or by two-way ANOVA. Data were analysed
using GraphPad Prism.
Results
Expression of IP3 3-KA in PC12 Cells Results in an
Inhibition of Neurite Outgrowth
In order to determine how IP3 3-KA activity impacts on NGF
driven neurite outgrowth from PC12 cells, we first generated
numerous cell lines stably expressing GFP-tagged full length IP3 3-
KA. We sorted one of these lines by FACS to produce cell lines
with different levels (designated high and low) of recombinant
protein expression (as defined by the intensity of the GFP signal).
Neuronal differentiation was induced by the addition of NGF, and
we investigated the sub-cellular localisation of recombinant IP3 3-
KA-GFP by confocal microscopy. We initially observed that very
few IP3 3-KA-GFP expressing cells differentiated following the
addition of NGF, and that the neurites of those cells that did
differentiate were clearly shorter than their wild type counterparts.
Where neurites were observed, IP3 3-KA-GFP fluorescence was
detected throughout their full length, and was enriched at the
growth cone. We then used fluorescently labeled phalloidin to
label F-actin, and confirmed that IP3 3-KA-GFP colocalises with
F-actin at the tip of growing neurites (Figure 1A).
The effects of IP3 3-KA expression on neurite outgrowth were
quantified using the Cellomics Arrayscan instrument for high
content analysis and the Cellomics Neurite Outgrowth algorithm
(detailed in the materials and methods section). Cells were
incubated in the presence of NGF to induce neurite outgrowth
and fixed after four days in culture. High levels of IP3 3-KA
expression resulted in a dramatic decrease (by 61%) in the number
of cells with neurites compared with wild type control cells whilst
Figure 1. IP3 3-KA co-localises with F-actin at the PC12 cell growth cone, and inhibits neurite outgrowth. (A) Growth cone of PC12 cell
stably expressing high levels of IP3 3-KA-GFP, fixed ten days after culture in the presence of 100 ng/ml NGF, and labeled with phalloidin-594. IP3 3-KA-
GFP co-localises with F-actin. Scale bar is 10 mm. (B) Quantitative analysis of the effects of IP3 3-KA-GFP expression on neurite outgrowth. Neurite
outgrowth was quantified using the Cellomics Arrayscan Neurite Outgrowth algorithm to measure the percentage of cells with neurites, and average
neurite length (described in full in materials and methods). IP3 3-KA expression results in an inhibition of neurite outgrowth. Data are presented as
mean +/2 SEM. ***p,0.001, by ANOVA with post-hoc analysis. (C) Arrayscan images of PC12 cells expressing varying levels of IP3 3-KA-GFP, fixed four
days after culture in the presence of 100 ng/ml NGF, and labeled using Hoescht 33342 and the Cellomics Neurite Outgrowth HitKit to identify
neuritis. Scale bar is 100 mm.
doi:10.1371/journal.pone.0032386.g001
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lower levels of IP3 3-KA expression resulted in less reduction
(14%) (Figure 1B). We also analysed the average length of neurites
and confirmed that expression of IP3 3-KA resulted in cells with
shorter neurites than those emanating from control cells
(Figure 1B). Cells expressing high levels of IP3-3KA produced
neurites that were on average 46% shorter than those produced by
control cells, whilst cells expressing lower levels of IP3-3KA had
neurites that were shorter on average by 34%. These data show a
correlation between level of expression of IP3 3-KA and
phenotypic effect. They also demonstrate that IP3 3-KA functions
to oppose the actions of NGF on PC12 cells, and that this results in
a dramatic reduction in neurite outgrowth, as can clearly be seen
in images acquired using the Arrayscan (Figure 1C).
The enzymatic activity of IP3 3-KA is principally
responsible for inhibiting NGF driven neurite outgrowth
We reasoned that IP3 3-KA could be inhibiting neurite outgrowth
either by virtue of its catalytic activity, or by its ability to bind to F-
actin. In order to address this issue, we generated cell lines stably
expressing truncated or mutated IP3 3-KA-GFP. 66-459 IP3 3-KA-
GFP lacks the N-terminal amino acids necessary for binding to F-
actin and is therefore rendered cytosolic [8]. D260A/K262A IP3 3-
KA-GFP is identical to the full-length construct except for two point
mutations in the catalytic domain which render the enzyme
catalytically inactive [23,26]. Cells were again sorted by FACS to
produce high and low expressing stable cell lines. In contrast to cells
expressing wild type IP3 3-KA-GFP, cells expressing ‘kinase dead’
D260A/K262A IP3 3-KA-GFP differentiated at a similar rate to
their wild type counterparts in the presence of NGF. Kinase dead IP3
3-KA-GFP localised in the same way as the wild type construct, and
was enriched at the growth cone (Figure 2A, upper panel).
Conversely, cytosolic 66-459 IP3 3-KA-GFP was distributed
uniformly along neurites, and was not enriched at the growth cone
(Figure 2A lower panel). This suggests that the actin binding domain
of IP3 3-KA is required to enrich the enzyme at the growth cone of
differentiating PC12 cells. We then quantified the effects of the
mutant constructs on neurite outgrowth using the same criteria as for
the full-length construct. High levels of kinase dead IP3 3-KA-GFP
expression resulted in an increase in neurite outgrowth of 25% in the
number of cells with neurites compared with control cells (Figure 2B).
Lower levels of expression had no effect. This suggests that the kinase
dead construct is capable of acting as a partial dominant-negative. In
contrast, high levels of expression of the cytosolic IP3 3-KA-GFP
construct resulted in a decrease (by 57%) in the number of cells with
Figure 2. The catalytic activity of IP3 3-KA opposes NGF-driven neurite outgrowth from PC12 cells. (A) Localisation of mutant IP3 3-KA
constructs in PC12 cell neurites. IP3 3-KA D260A/K262A-GFP is enriched at the growth cone, whilst IP3 3-KA 66-459-GFP is not. Scale bar is 10 mm. (B)
Quantitative analysis of the effects of mutated IP3 3-KA expression on neurite outgrowth. D260A/K262A-GFP overexpression results in an increase in
the number of cells with neurites and decreases neurite length. IP3 3-KA 66-459-GFP expression results in a decrease in both indices of neurite
outgrowth. Data are presented as mean +/2 SEM. *p,0.05, ***p,0.001, by ANOVA with post-hoc analysis. (C) Arrayscan images of PC12 cells
expressing mutant IP3 3-KA-GFP, fixed four days after culture in the presence of 100 ng/ml NGF, and labeled using Hoescht 33342 and the Cellomics
Neurite Outgrowth HitKit to identify neuritis. Scale bar is 100 mm.
doi:10.1371/journal.pone.0032386.g002
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neurites compared with wild type controls (Figure 2B). These results
suggest that the catalytic activity of the IP3 3-KA is essential for the
inhibition of differentiation caused by expression of the full-length
enzyme. High levels of expression of the kinase dead IP3 3-KA
resulted in cells with shorter neurites (by 19%) compared with wild
type controls (Figure 2B), whilst low levels of expression had no effect
on neurite length. Cells expressing high levels of the cytosolic IP3 3-
KA exhibited neurites that were 28% shorter than controls
(Figure 2B). This is not as marked an effect as that caused by
expression of the full-length enzyme (p,0.001 by two-way
ANOVA). Low levels of expression of the cytosolic IP3 3-KA had
no effect on neurite length, compared with a 32% reduction
exhibited by the cells expressing low levels of the full-length enzyme.
It would therefore appear that amino acids 1–65 are necessary to
enrich IP3 3-KA at growth cone actin, where it functions to inhibit
neurite length, principally by virtue of its catalytic activity but also by
regulating the actin cytoskeleton. Representative images of each of
these cell lines (Figure 2C) highlight the fact that the catalytic activity
of IP3 3-KA is principally responsible for the inhibition of NGF-
driven neurite outgrowth from PC12 cells.
Inhibition of IP3 3-kinase activity enhances neurite
outgrowth from PC12 cells
In order to investigate the effects of endogenous IP3 3-kinase
activity in PC12 cells, we investigated the effects of a number of
reported IP3 3-kinase inhibitors [24,27] on neurite outgrowth. We
found that most of these enhanced neurite outgrowth from IP3 3-
KA expressing cells, and chose molecule C5 for further investiga-
tion. C5 is a purine-based inhibitor of IP3 3-kinase that is reported to
have an IC50 of 10.2 mM in vitro [24]. We therefore investigated the
effects of C5 on PC12 neurite outgrowth at concentrations of 10 to
40 mM.Cells expressing high levels of IP3 3-KA were cultured in the
presence of NGF and C5. Low doses (10–20 mM) of C5 had little
effect. However at higher doses (30–40 mM) C5 overcame the
inhibition on neurite outgrowth imposed by expression of IP3 3-KA,
giving rise to an increase in the number of cells with neurites, and an
increase in average neurite length (Figure 3A). We then investigated
the effects of IP3 3-kinase inhibition on neurite outgrowth from wild
type PC12 cells and found that increasing doses of C5 resulted in
increases in both the number of cells with neurites and the length of
neurites (Figure 3A). We found that the number of neurite bearing
cells in wild type and IP3 3-KA expressing cell types equalised as C5
dose increased, reflecting a dose dependent affinity of C5 for IP3 3-
kinase, and further indicating that the catalytic activity of IP3 3-
kinase opposes NGF driven PC12 cell differentiation. However, C5
inhibition did not completely overcome the inhibition of neurite
length caused by IP3 3-KA overexpression, again suggesting that it
hinders neurite extension partly via its catalytic activity, but also by
an additional mechanism (most likely by interfering with the actin
cytoskeleton). Representative images of these cells underline the
effects of IP3 3-kinase inhibition on neurite outgrowth from PC12
cells, illustrating that as the dose of C5 increases, neurites become
increasingly more streamlined, and better defined (Figure 3B and
C). These results demonstrate that endogenous IP3 3-kinase activity
opposes NGF driven neurite outgrowth from PC12 cells, and
suggest that the enzyme functions to oppose the NGF dependant
intracellular signals that trigger differentiation.
IP3 3-kinase activity attenuates ERK phosphorylation via a
mechanism which appears distinct from the removal of
IP3
We next questioned the mechanism by which IP3 3-kinase
activity opposes NGF driven neurite outgrowth, reasoning that the
inhibition of neurite outgrowth caused by IP3KA over-expression
was due either to the metabolism of IP3 or to increased production
of IP4. We argued that if the increased metabolism of IP3 caused
by IP3 3-KA activity was responsible for inhibiting PC12 cell
differentiation, then blockade of the IP3 receptor would have a
similar effect. We therefore investigated the effects of IP3 receptor
blockade during NGF driven neurite outgrowth using the cell
permeable IP3 receptor inhibitor Xestospongin C (XeC). We
found that IP3 receptor blockade with XeC had no effect on the
number of wild type PC12 cells with neurites, or on neurite length
(p,0.05 by ANOVA) (Figure 4A). This suggests that increased
metabolism of IP3 caused by IP3 3-KA overexpression is
insufficient to inhibit PC12 cell differentiation. We also treated
cells expressing high levels of IP3 3-KA with NGF in the presence
of XeC, and found that rather than compounding the effects of
elevated IP3 3-kinase activity, XeC overcame some of the IP3 3-
KA dependent inhibition of neurite outgrowth (Figure 4A). This
suggests that reducing intracellular calcium by blocking its release
from internal stores decreases IP3 3-KA activity, and is in keeping
with findings that IP3 3-KA activity is calcium dependent [28,29].
Our data are therefore consistent with the hypothesis that IP3 3-
kinase opposes the actions of NGF on PC12 cells via the
generation of IP4, and are in agreement with previous findings
that, whilst stimulation of PC12 cells with NGF results in the
generation of IP3 and IP4, signaling via IP3 does not appear to
contribute substantially to the differentiation process [30,31]. Our
data our also consistent with previous reports that XeC treatment
has little effect on NGF-induced neurite outgrowth from PC12
cells [32,33]. We therefore questioned the mechanisms by which
IP4 might prevent PC12 cell differentiation, and focused on the
ERK signaling pathway as sustained activation of ERKs is
reported to be essential for the NGF mediated differentiation of
PC12 cells [34].
We investigated the effects of C5 inhibition of IP3 3-kinase on
ERK phosphorylation in control cells and in cells expressing high
levels of IP3 3-KA. Serum starved cells were preincubated with
either 40 mM C5 or vehicle for 30 minutes prior to stimulation
with a low dose of NGF (1 ng/ml) and subsequently lysed at
various time points. The onset of ERK phosphorylation was slow
following stimulation with 1 ng/ml of NGF, and reached a peak
after 30 minutes. Comparison of cells expressing high levels of IP3
3-KA with wild-type controls revealed that ERK signaling is
attenuated in the IP3 3-KA expressing cells after stimulation with
1 ng/ml NGF (Figure 4 B and C). Furthermore, pre-incubation
with 40 mM C5 resulted in an increase in the amount of
phosphorylated ERKs in both the wild type cells, and cells
expressing high levels of IP3 3-KA. Quantification by densitometry
revealed that 30 minutes after NGF stimulation, ERK phosphor-
ylation is reduced by 66% in the cells expressing high levels of IP3
3-KA compared with wild type controls (Figure 4C). Furthermore,
inhibition of IP3 3-kinase by C5 in wild type cells resulted in a 56%
increase in ERK phosphorylation (Figure 4C). A similar effect was
seen in cells expressing high levels of IP3 3-KA. These results
demonstrate that IP3 3-kinase activity attenuates ERK signaling in
NGF stimulated PC12 cells, contributing to an inhibition of
neurite outgrowth, most likely as a result of IP4 production.
Discussion
We have demonstrated that elevated expression of IP3 3-KA
dramatically inhibits NGF driven PC12 cell differentiation, and
that this occurs principally as a result of the kinase activity of the
enzyme. We have also shown that inhibiting endogenous IP3 3-
kinase leads to enhanced neurite outgrowth from NGF stimulated
IP3 3-Kinase Opposes NGF Driven Neurite Outgrowth
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PC12 cells, suggesting that endogenous IP3 3-kinase functions to
oppose the actions of NGF on PC12 cells. This inhibition of PC12
cell differentiation involves the attenuation of signaling through
ERK, and most likely occurs via the production of IP4 because
inhibition of the IP3 receptor has no effect on neurite outgrowth
from wild type PC12 cells. IP3 3-kinase therefore appears to
mediate a negative feedback mechanism which functions (via the
production of IP4) to oppose the actions of NGF on PC12 cells.
We chose to investigate IP3 3-KA in a model neuronal cell
because it is this isoform of IP3 3-kinase that is enriched in the
dendritic spines of hippocampal neurons. The majority of previous
studies examining the effects of signaling via IP3 3-kinase have
been undertaken in various immune cells (B-cells, T-cells and
neutrophils [4,9,10,11,12,13,14,15,16], and there have been no
studies to examine the impact of signaling via IP3 3-kinase in
neuronal cells. Whilst PC12 cells do not represent hippocampal
Figure 3. Inhibition of IP3 3-kinase increases neurite outgrowth from PC12 cells, and IP3 3-KA-PC12 cells. (A) Analysis of the effects of
C5 on wild type PC12 cells and cells expressing high levels of IP3 3-KA. Differentiating PC12 cells in the presence of C5 results in an increase in two
indices of neurite outgrowth. Data are presented as mean +/2 SEM. ***p,0.001, by ANOVA with post-hoc analysis. (B) Arrayscan images of PC12 cells
expressing high levels of IP3 3-KA, fixed four days after culture in the presence of 100 ng/ml NGF, and labeled using Hoescht 33342 and the Cellomics
Neurite Outgrowth HitKit to identify neurites (using a 106objective). (C) Arrayscan images of PC12 cells, fixed four days after culture in the presence
of 100 ng/ml NGF, and labeled as for (B). Scale bar is 100 mm.
doi:10.1371/journal.pone.0032386.g003
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Figure 4. IP3 3-KA activity results in attenuation of ERK phosphorylation. IP3 does not appear to be required for NGF driven neurite
outgrowth. (A) Analysis of the effects of XeC blockade of the IP3 receptor, on PC12 cells expressing high levels of IP3 3-KA and on wild type PC12 cells.
XeC has no effect on control PC12 cells, but partially overcomes the inhibition of neurite outgrowth caused by IP3 3-KA expression. Data are
presented as mean +/2 SEM. **p,0.01, by ANOVA with post-hoc analysis. (B) Determination of ERK activation in control PC12 cells and IP3 3-KA
expressing cells using a suboptimal dose of NGF, in the presence of either 40 mM C5 or vehicle. Lower blot represents ERK activation as detected by
phospho-specific antibodies against ERK1 and ERK2. Upper blot represents total ERK, as detected using an antibody that detects both ERK1 and ERK2.
All antibodies were visualised with an HRP conjugated secondary antibody. The blot shown is representative of three independent experiments. (C)
Densitometric quantification of ERK activation, as depicted in (B). **p,0.01, Data are presented as mean +/2 SEM. ***p,0.001, by ANOVA with post-
hoc analysis. IP3 3-KA expression attenuates ERK activation, whilst C5 inhibition of IP3 3-kinase results in increased ERK activity.
doi:10.1371/journal.pone.0032386.g004
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neurons, they have provided a platform to investigate the
consequences of signaling via IP3 3-kinase in a model system for
neuronal differentiation. It is important to note that all of the
elements of the pathway we have described are present in neurons
in the hippocampus [35] where IP3 is generated post-synaptically
by the activation of metabotropic glutamate receptors [36]. We
have demonstrated, using a neuronal cell line, that IP3 3-KA can
act to attenuate ERK signaling and we suggest that if a similar
process occurs within dendritic spines it would have significant
consequences in terms of the regulation of post-synaptic
excitability, and would be in keeping with the finding that mice
lacking IP3 3-KA have enhanced LTP [18]. Further studies are
therefore required to determine how the pathway we have
investigated in PC12 cells might be applied to the regulation of
post-synaptic signaling.
We have not investigated the other signaling pathways activated
by the binding of NGF to the TrkA receptor. TrkA also signals via
phosphoinositide 3-kinase (PI 3-kinase) and PIP3, and IP4 is
reported to inhibit PIP3 signaling since depletion of IP4 enhances
PIP3 signaling in neutrophils [16]. Furthermore, IP3 3-KB is
reported to regulate myelopoiesis via the production of IP4 and the
subsequent down-regulation of signaling via PIP3 and AKT [15].
It is possible then that increased IP4 production in PC12 cells
expressing elevated levels of IP3 3-KA could also inhibit signaling
via PIP3, and contribute to the inhibition of neurite outgrowth.
However, sustained ERK activation is considered to be the
principal signal for NGF driven neurite outgrowth from PC12
cells, and it is possible that there is a direct link between IP4
production and ERK attenuation. The most likely candidates for
this role are the IP4 binding proteins Gap1IP4BP and GAP1M.
These are closely related proteins that are both reported to exhibit
GTPase activating (GAP) activity towards Ras, whilst Gap1IP4BP
is also reported to exhibit GAP activity towards the Ras related
protein Rap1 [37]. As the sustained activation of ERKs
responsible for NGF driven differentiation of PC12 cells is
mediated by Rap1 [34], it may be that the dual GAP activity of
Gap1IP4BP on both Ras and Rap is limiting the ERK dependent
outgrowth process. In support of this hypothesis, it is reported that
Gap1IP4BP is down-regulated during the differentiation of PC12
cells to a neuronal phenotype, suggesting that Gap1IP4BP exists as
an obstacle to NGF driven neurite outgrowth [38]. It would
therefore be interesting to determine whether changes in IP4
concentration (as a result of IP3 3-kinase activity) affect
GAP1IP4BP activity towards Rap1 and Ras in NGF stimulated
PC12 cells. In summary, our findings suggest that IP3 3-kinase
functions to negatively regulate the NGF dependent signals that
lead to the differentiation of PC12 cells. This most likely occurs via
the production of IP4 leading to attenuation of signaling through
ERK. We suggest that this signaling pathway may have relevance
in other neuronal cells where it may be involved in the regulation
of post synaptic signaling.
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